Library

Peptide blend

CJC-1295 no DAC & Ipamorelin (10mg Blend Vial)

Complete dosage protocol and reconstitution guide for CJC1295 NO DAC + Ipamorelin (10mg Blend Vial).

Updated November 25, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismCJC1295 NO DAC + Ipamorelin 10mg dosage protocol supports enhanced growth hormone release and recovery through daily subcutaneous injections. Typical total daily dose ranges from 300–600 mcg for most protocols 5-days-on, 2-days-off schedule is common to prevent receptor desensitization Gradual titration approach to optimize tolerability and results Reconstitute to a practical concentration for accurate syringe measurements Store lyophilized in the freezer; keep reconstituted vials refrigerated
Dosingranges from 300–600 mcg for most protocols 5-days-on, 2-days-off schedule is common to prevent receptor desensitization Gradual titration approach to optimize tolerability and results Reconstitute to a practical concentration for accurate syringe measurements Store lyophilized in the freezer; keep reconstituted vials refrigerated
ReconstitutionAdd 3.0 mL diluent and verify in the calculator.
StorageLyophilized vials in the freezer; reconstituted vials in the refrigerator

Calculator preset

Run the vial math before tracking.

Doses are total blend . At 3,333 mcg/mL, 1 unit ~ 33.3 mcg ; at 5,000 mcg/mL, 1 unit = 50 mcg on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

CJC1295 NO DAC + Ipamorelin 10mg dosage protocol supports enhanced growth hormone release and recovery through daily subcutaneous injections. Typical total daily dose ranges from 300–600 mcg for most protocols 5-days-on, 2-days-off schedule is common to prevent receptor desensitization Gradual titration approach to optimize tolerability and results Reconstitute to a practical concentration for accurate syringe measurements Store lyophilized in the freezer; keep reconstituted vials refrigerated

Reconstituteto a practical concentration for accurate syringe measurements Store lyophilized in the freezer; keep reconstituted vials refrigerated
Reference doseranges from 300–600 mcg for most protocols 5-days-on, 2-days-off schedule is common to prevent receptor desensitization Gradual titration approach to optimize tolerability and results Reconstitute to a practical concentration for accurate syringe measurements Store lyophilized in the freezer; keep reconstituted vials refrigerated
Easy measuringDoses are total blend . At 3,333 mcg/mL, 1 unit ~ 33.3 mcg ; at 5,000 mcg/mL, 1 unit = 50 mcg on a U-100 syringe.
StorageReview the source instructions and storage notes before handling any vial.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~3,333 mcg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–4300 mcg (once daily) ~9 unitsSee calculator
Weeks 5–8500 mcg (once daily) ~15 unitsSee calculator
Weeks 9–12600 mcg (once daily) ~18 unitsSee calculator
Weeks 13–16(Optional) 700 mcg (once daily) ~21 units Reconstitute with 3 mL of bacteriostatic water to achieve an approximate 3,333 mcg/mL concentration. Note that 300 mcg requires about 9 units, which is slightly below 10. If h...See calculator

ranges from 300–600 mcg for most protocols 5-days-on, 2-days-off schedule is common to prevent receptor desensitization Gradual titration approach to optimize tolerability and results Reconstitute to a practical concentration for accurate syringe measurements Store lyophilized in the freezer; keep reconstituted vials refrigerated

Advanced / Aggressive Approach

Phase / setup Dose & frequency Volume / units
Weeks 1–4600 mcg (once daily) ~12 unitsSee calculator
Weeks 5–8800 mcg (once daily) ~16 unitsSee calculator
Weeks 9–121,000 mcg (once daily) ~20 unitsSee calculator
Weeks 13–16(Optional) 1,200 mcg (once daily) ~24 units For those requiring higher daily doses (600–1,200 mcg), reconstitute with 2 mL to achieve 5,000 mcg/mL . This helps keep injection units comfortably above 10. Draw 2.0 mL of...See calculator

Reconstitution Steps

  1. Confirm the vial amount, unit, and diluent amount before entering values in the calculator.
  2. Add diluent slowly down the inner wall of the vial when reconstitution is appropriate for the compound.
  3. Swirl or roll gently until dissolved; avoid shaking unless the product instructions specifically say otherwise.
  4. Label the vial with the date and concentration, then store according to the protocol and product instructions.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 wks ≈ 2 vials 12 wks ≈ 3 vials 16 wks ≈ 4 vials (More if planning higher doses or extended use)
    Insulin Syringes 8 wks ≈ 40 syringes (daily use, 5 days on/2 days off) 12 wks ≈ 60 syringes 16 wks ≈ 80 syringes
      Bacteriostatic Water 1× 30 ml (or more as needed)
        Alcohol Swabs 1 box

          Protocol Overview

          • Goal: Enhance growth hormone release and support recovery
          • Schedule: Typically 5 days on, 2 days off (e.g., Monday–Friday)
          • Dose Range: 300–600 mcg daily for most researchers, with advanced users reaching 1,000+ mcg
          • Reconstitution: Aim for 2–3 mL for easy measuring on insulin syringes
          • Storage: Lyophilized vials in the freezer; reconstituted vials in the refrigerator

          Dosing Protocol

          • Suggested once-daily injection approach for consistent GH pulses.
          • Daily Dose: Start at ~300 mcg; gradually increase as tolerated
          • Frequency: Daily injections, 5 on/2 off per week
          • Cycle Length: 8–16 weeks, followed by a rest period to maintain receptor sensitivity Advanced Doses: May exceed 600 mcg daily based on research goals
          • Timing: Best on an empty stomach; morning or before bed

          Storage Instructions

          • Review the source instructions and storage notes before handling any vial.
          • Storage: Lyophilized vials in the freezer; reconstituted vials in the refrigerator
          • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

          04 · Good to know

          Important Notes

          • Practical tips to enhance safety and efficacy.
          • Rotate injection sites and always use new, sterile syringes.
          • For best results, inject on an empty stomach and wait ~30 minutes before eating.
          • Monitor for adverse reactions; discontinue use if serious issues arise.
          • Track progress weekly; adjust dosage and protocol duration as research suggests.

          05 · How it works

          How This Works

          CJC1295 NO DAC + Ipamorelin 10mg dosage protocol supports enhanced growth hormone release and recovery through daily subcutaneous injections.

          Typical total daily dose ranges from 300–600 mcg for most protocols 5-days-on, 2-days-off schedule is common to prevent receptor desensitization Gradual titration approach to optimize tolerability and results Reconstitute to a practical concentration for accurate syringe measurements Store lyophilized in the freezer; keep reconstituted vials refrigerated

          The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

          06 · Daily habits

          Lifestyle Factors

          • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
          • Track body metrics only if they are relevant to the user's goal and approved data sources.
          • Use consistent timing and logging habits so adherence data is meaningful.

          07 · What to expect

          Potential Benefits & Side Effects

          • CJC-1295 no DAC & Ipamorelin observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
          • This section is not a claim of therapeutic benefit.

          08 · Technique

          Injection Technique

          Pre-injection preparation
          • Wash hands with soap and water.
          • Wipe the vial stopper and chosen site with alcohol, then let both dry.
          • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
          Injection procedure
          • Use the route and needle technique directed by a qualified professional or product instructions.
          • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
          • Do not reuse needles or syringes.
          Post-injection care
          • Dispose of sharps in a puncture-resistant container.
          • Return stored items promptly to the correct temperature.
          • Log dose, site, date, time, inventory change, and any observation.

          09 · Evidence

          References

          TNHL options

          Peptide collections stay passive.

          Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

          Related pages

          Keep researching